Search hospitals > Pennsylvania > Allentown
Lehigh Valley Hospital-Cedar Crest
Claim this profileAllentown, Pennsylvania 18103
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Recurrence
443 reported clinical trials
33 medical researchers
Summary
Lehigh Valley Hospital-Cedar Crest is a medical facility located in Allentown, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Recurrence and other specialties. Lehigh Valley Hospital-Cedar Crest is involved with conducting 443 clinical trials across 763 conditions. There are 33 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Jacob A. Troutman.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
70 reported clinical trials
127 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
45 reported clinical trials
99 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Jacob A. TroutmanLehigh Valley Hospital-Cedar Crest7 years of reported clinical research
Expert in Tumors
Studies Leukemia
32 reported clinical trials
83 drugs studied
Clinical Trials running at Lehigh Valley Hospital-Cedar Crest
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Renal Cell Carcinoma
Gastric Cancer
Multiple Myeloma
Tumors
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Lehigh Valley Hospital-Cedar Crest?
Lehigh Valley Hospital-Cedar Crest is a medical facility located in Allentown, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Recurrence and other specialties. Lehigh Valley Hospital-Cedar Crest is involved with conducting 443 clinical trials across 763 conditions. There are 33 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Jacob A. Troutman.
Where is Lehigh Valley Hospital-Cedar Crest located?
**Directions to Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania:**
- From the Northeast Extension of the Pennsylvania Turnpike, take the Lehigh Valley exit.
- Follow Route 22 East to Route 309 South, which merges with I-78 East, and proceed to Cedar Crest Boulevard exit 55.
- Turn right at the end of the exit ramp and again at the traffic light onto the hospital's main entrance road, following signs to visitor parking.
Who should I call to ask about financial aid or insurance network?
**Lehigh Valley Hospital-Cedar Crest Financial Assistance Contact Information:**
- **Address:**
Lehigh Valley Health Network
ATTN: Patient Financial Services, Financial Counselor
2100 Mack Blvd
PO BOX 4120
Allentown, PA 18105-4120
- **Financial Counselor Office Message Line:**
484-884-0840
*Available Monday through Friday, 8:00 AM to 4:00 PM EST.*
What insurance does Lehigh Valley Hospital-Cedar Crest accept?
Lehigh Valley Hospital-Cedar Crest accepts a wide range of insurance plans, such as Aetna, AmeriHealth NJ, Capital Blue Cross, Cigna, Geisinger Health Plan, Highmark Blue Shield, Independence Blue Cross, United Healthcare, UPMC, and Veterans Benefits. Coverage includes commercial, Medicare Advantage, Medicaid, and Workers Compensation. For specific information regarding coverage, contacting the hospital or insurance provider directly is recommended.
What awards or recognition has Lehigh Valley Hospital-Cedar Crest received?
Lehigh Valley Hospital-Cedar Crest, located in Allentown, Pennsylvania, is celebrated for its exceptional orthopedic care, ranking among the top 10 hospitals in the state according to U.S. News & World Report. It stands as the leading hospital in the Allentown metro area for the 10th consecutive year. The institution has also been honored with the Get With The Guidelines®-Stroke Gold Plus Award by the American Heart Association, recognizing its outstanding stroke care.